spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

TP3 Global receives Royal recognition by winning the Queen’s Awards for Enterprise 2018

TP3 Global


Birmingham, UK, 23 April 2018 – TP3 Global, a leading global innovator and provider of thermal protection for temperature sensitive cargo, is pleased to announce it has been awarded the 2018 Queen’s Awards for Enterprise in the International Trade category for its globally-recognised Silverskin™ brand.

The Queen’s Awards for Enterprise are the United Kingdom’s most prominent business awards, which commend enterprise excellence. TP3 Global won the recognition for outstanding growth in overseas sales over the past three years. SilverSkinTM has become a major brand in the market, recognised, approved and used by the leading pharmaceutical companies around the world. TP3 Global has seen rapid growth thanks to a strong focus on providing consistent quality and innovative solutions to a worldwide client base.

Clive Wheeldon, President of TP3 Global, commented: “We are extremely proud to achieve the prestigious Queen’s Award for Enterprise for international trade. Our commitment to providing market-leading products, innovation and high-quality customer service has resulted in working with the industry’s leading pharmaceutical companies.

 “We continue to invest heavily in R&D, global footprint and customer service ensuring we stay at the forefront of the market. We are delighted to see many of the world’s pharmaceutical companies utilise SilverskinTM to maintain the integrity of their products in their supply chain. Our team is very proud to have won a prestigious Queen’s Award that recognises our on-going commitment to innovation and excellence for international trade.”

 The Queen’s Awards for Enterprise first began in 1966. They are awarded to businesses for outstanding achievement in four categories International Trade, Innovation, Sustainable Development and also for Promoting Opportunity (through social mobility).



phone 01962 435006
email lisa@amplify-pr.co.uk
web www.tp3global.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Mologic Signs Agreements with Medisur and Peripal to Distribute PERiPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®, a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD). Both companies are specialists in the development and distribution of products which enable patient self-management and will supply PERiPLEX as part of a highly complementary product portfolio in key European markets including France, Germany, Italy, The Netherlands, Austria and Switzerland.
More info >>


White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

Industry Events

Clinical Innovation Partnerships 2018

3-4 July 2018, Radisson Blu Hotel, Zurich Airport

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement